Syros Pharmaceuticals Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Syros Pharmaceuticals Inc
CIK #0001556263
EDGAR Form CIK 2011 - 2026
10-K [0001556263]
10-Q [0001556263]
3 [0001556263]
4 [0001556263]
5 [0001556263]
8-K [0001556263]
D [0001556263]
SC 13D [0001556263]
SC 13G [0001556263]
Form 13D/13G Filer Form 13D/13G Subject Filed
Blue Owl Capital Holdings LP Syros Pharmaceuticals Inc [2024-02-14]
Point72 Asset Management LP Syros Pharmaceuticals Inc [2024-01-02]
Samsara Biocapital LP Syros Pharmaceuticals Inc [2023-10-20]
Adage Capital Partners GP LLC Syros Pharmaceuticals Inc [2023-01-25]
Avidity Partners Management LP Syros Pharmaceuticals Inc [2022-09-20]
Deep Track Capital LP Syros Pharmaceuticals Inc [2022-09-19]
Syros Pharmaceuticals Inc TYME Technologies Inc [2022-07-13]
TYME Technologies Inc Syros Pharmaceuticals Inc [2022-07-13]
BlackRock Inc Syros Pharmaceuticals Inc [2022-07-08]
Artal International SCA Syros Pharmaceuticals Inc [2022-02-11]
View All
Form 3/4/5 Subject 2011 - 2026
Simonian Nancy A
Syros Pharmaceuticals Inc
Quirk Gerald E
Chee Conley
Haas Jason
Stephens Kristin
Roth David
Akkaraju Srinivas
Young Richard A
Dunsire Deborah
Wirth Peter
Fanucci Marsha
Eckhardt Sue Gail
Tyson Timothy
OH Andrew M
Alles Mark J
Olson Eric R
Sharp Phillip A
Nashat Amir
Springhorn Jeremy P
Ferra Joseph J Jr
Bybee Clinton
Nelsen Robert
Arch Venture Fund VII LP
Crandell Keith
Arch Venture Partners VII LP
Arch Venture Partners VII LLC
Shaw Alice Tsang
Sato Vicki L
Bonney Michael W
Afeyan Noubar
DeSimone Colleen Elizabeth
Flagship Ventures Fund IV LP
Flagship VentureLabs IV LLC
Flagship Ventures Fund IV General Partner LLC
Kania Edwin
Flagship Ventures Fund IV-RX LP
Patel Sanj K
Kuvalanka Kyle D
Bancel Stephane
Polaris Entrepreneurs' Fund VII LP
Polaris Management Co VII LLC
Polaris Partners VII LP
WuXi PharmaTech Healthcare Fund I LP
Redmile Group LLC
Green Jeremy
Elms Steve
Aisling Capital Partners III LP
Schiff Andrew N
Aisling Capital III LP
Aisling Capital Partners III LLC
Purcell Dennis J
Deerfield Special Situations Fund LP
Deerfield Management Company LP
Deerfield Capital LP
Deerfield Mgmt III LP
Deerfield Private Design Fund III LP
Flynn James E
WuXi Healthcare Ventures II LP
JEB Syros Trust
Perspecta Trust LLC
Conde Jorge
Gray Nathanael
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-12-02 Sell 37,070 $0.27 10,009
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-11-25 Sell 134,713 $0.27 36,373
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-11-19 Sell 46,657 $0.22 10,265
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-11-18 Sell 36,133 $0.22 7,949
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-11-18 Sell 137,803 $0.21 28,939
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-11-18 Sell 12,099 $0.20 2,420
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-11-18 Sell 134,797 $0.20 26,959
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Option exercise 18,875
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Tax withheld 8,707 $2.09 18,198
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Tax withheld 5,624 $2.09 11,754
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Tax withheld 6,104 $2.09 12,757
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Tax withheld 6,776 $2.09 14,162
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Option exercise 17,000
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
2024-10-31 Option exercise 18,875 $0.00
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
2024-10-31 Option exercise 17,000 $0.00
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
2024-10-31 Option exercise 18,875 $0.00
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Option exercise 18,875
Syros Pharmaceuticals Inc SYRS
Restricted Stock Units · derivative
2024-10-31 Option exercise 17,000 $0.00
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Option exercise 17,000
Syros Pharmaceuticals Inc SYRS
Common Stock
2024-10-31 Option exercise 40,125
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com